{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:57:19Z","timestamp":1692842239427},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T00:00:00Z","timestamp":1411430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107627","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T17:52:04Z","timestamp":1411494724000},"page":"e107627","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of Ser102 and Ser104 as Regulators of cGMP Hydrolysis by PDE5A"],"prefix":"10.1371","volume":"9","author":[{"given":"Julie","family":"Car\u00f8e Nordgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Schack","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen","family":"Gammeltoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Rostrup","family":"Kruuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine","volume":"22","author":"LH Lassen","year":"2002","journal-title":"Cephalalgia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/0333102410368444","article-title":"Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura","volume":"30","author":"JM Hansen","year":"2010","journal-title":"Cephalalgia"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00001756-199308000-00008","article-title":"Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain","volume":"4","author":"J Olesen","year":"1993","journal-title":"Neuroreport"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1526-4610.2012.02212.x","article-title":"CGRP and NO in the trigeminal system: mechanisms and role in headache generation","volume":"52","author":"K Messlinger","year":"2012","journal-title":"Headache"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kleppisch T, Feil R (2009) cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour. Handb Exp Pharmacol: 549\u2013579.","DOI":"10.1007\/978-3-540-68964-5_24"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"M Conti","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neulet.2006.05.045","article-title":"Phosphodiesterase 3 and 5 and cyclic nucleotide-gated ion channel expression in rat trigeminovascular system","volume":"404","author":"LS Kruse","year":"2006","journal-title":"Neurosci Lett"},{"key":"ref8","first-page":"503","article-title":"Phosphodiesterases 3 and 5 express activity in the trigeminal ganglion and co-localize with calcitonin gene-related peptide","volume":"(7)","author":"JC Nordgaard","year":"2013","journal-title":"Cephalalgia 34"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Francis SH, Corbin JD, Bischoff E (2009) Cyclic GMP-hydrolyzing phosphodiesterases. Handb Exp Pharmacol: 367\u2013408.","DOI":"10.1007\/978-3-540-68964-5_16"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00004647-200209000-00010","article-title":"The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects","volume":"22","author":"C Kruuse","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"SH Francis","year":"2010","journal-title":"Pharmacol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"AT Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"14971","DOI":"10.1016\/S0021-9258(18)77211-6","article-title":"Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP","volume":"265","author":"MK Thomas","year":"1990","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00432-010-0847-2","article-title":"Targeting PI3K in neuroblastoma","volume":"136","author":"V Spitzenberg","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref15","first-page":"2380","article-title":"Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines","volume":"55","author":"PS Cohen","year":"1995","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1526-4610.2009.01512.x","article-title":"Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5","volume":"50","author":"CJ Schankin","year":"2010","journal-title":"Headache"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-2952(99)00346-9","article-title":"Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity","volume":"59","author":"T Sudo","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrm911","article-title":"Cyclic nucleotide research \u2013 still expanding after half a century","volume":"3","author":"JA Beavo","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1046\/j.1432-1327.2000.01297.x","article-title":"Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities","volume":"267","author":"JD Corbin","year":"2000","journal-title":"Eur J Biochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","article-title":"Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion","volume":"169","author":"S Eftekhari","year":"2010","journal-title":"Neuroscience"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"DR Poyner","year":"2002","journal-title":"Pharmacol Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00127893-200109000-00002","article-title":"The pathophysiology of migraine","volume":"7","author":"SJ Tepper","year":"2001","journal-title":"Neurologist"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cellsig.2010.12.005","article-title":"Metal ion stimulators of PDE5 cause similar conformational changes in the enzyme as does cGMP or sildenafil","volume":"23","author":"JD Corbin","year":"2011","journal-title":"Cell Signal"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/brain\/awg009","article-title":"Migraine can be induced by sildenafil without changes in middle cerebral artery diameter","volume":"126","author":"C Kruuse","year":"2003","journal-title":"Brain"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/01.WCB.0000143536.22131.D7","article-title":"The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow","volume":"24","author":"S Birk","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8","article-title":"Nitric oxide in the pathogenesis of vascular disease","volume":"190","author":"H Li","year":"2000","journal-title":"J Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T17:10:22Z","timestamp":1650215422000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107627"}},"subtitle":[],"editor":[{"given":"David D.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,23]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107627","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,23]]}}}